Keyphrases
Disease Progression
100%
Human Immunodeficiency virus-1 Infection
100%
Neopterin
100%
Immune Markers
100%
Serum Neopterin
100%
Interferon-α (IFN-α)
75%
Human Immunodeficiency Virus Type 1 (HIV-1)
75%
CD4 Count
75%
Clinical Disease Progression
75%
Interleukin-6
50%
Immune Activation
50%
Soluble Markers
50%
Patient Monitoring
25%
Viral Load
25%
AIDS/HIV
25%
Lymphocytes
25%
Prognostic Value
25%
Clinical Outcomes
25%
CD4+
25%
CD4+ T
25%
MRNA Level
25%
Zidovudine
25%
Clinical Data
25%
Cell Count
25%
Cox Proportional Hazards Model
25%
Randomized Trial
25%
Disease Risk
25%
Clinical Benefit
25%
Laboratory Data
25%
Monotherapy
25%
TNF Receptor 1 (TNFR1)
25%
TNF Receptor 2 (TNFR2)
25%
Prognostic Information
25%
Serum Samples
25%
Validation Studies
25%
Strong Predictor
25%
Triglycerides
25%
AIDS Clinical Trials
25%
Resource-limited Settings
25%
β2-microglobulin (β2-MG)
25%
Reverse Transcriptase Inhibitors
25%
Serum Markers
25%
Didanosine
25%
Head-to-head Comparison
25%
Inhibitor Resistance
25%
MRNA Abundance
25%
Marker Data
25%
Robust Performance
25%
Stored Frozen Serum
25%
Marker Validation
25%
Biochemistry, Genetics and Molecular Biology
Human Immunodeficiency Virus 1
100%
Neopterin
100%
Immunity
100%
CD4 Lymphocyte Count
57%
RNA
42%
Interferon
42%
Interleukin 6
28%
Human Immunodeficiency Virus
14%
Clinical Trial
14%
CD4
14%
Triglyceride
14%
Virus Load
14%
Tumor Necrosis Factor Receptor
14%
Reverse Transcriptase
14%
Microglobulin
14%
Blood Plasma
14%
Didanosine
14%
Zidovudine
14%
Pharmacology, Toxicology and Pharmaceutical Science
Disease Exacerbation
100%
Human Immunodeficiency Virus 1 Infection
100%
Neopterin
100%
Interferon
50%
Human Immunodeficiency Virus 1
50%
Interleukin 6
33%
HIV
16%
Triacylglycerol
16%
Monotherapy
16%
Clinical Trial
16%
Zidovudine
16%
Tumor Necrosis Factor Receptor
16%
RNA Directed DNA Polymerase Inhibitor
16%
Didanosine
16%
Immunology and Microbiology
Human Immunodeficiency Virus 1
100%
Immunity
100%
Neopterin
100%
CD4 Lymphocyte Count
57%
interferon
42%
Interleukin 6
28%
Human Immunodeficiency Virus
14%
Blood Plasma
14%
Viral Load
14%
CD4+ T Lymphocyte
14%
Reverse Transcriptase
14%
Tumor Necrosis Factor Receptor
14%
Immune System
14%
Neuroscience
Human Immunodeficiency Virus
100%
Neopterin
100%
CD4
62%
Interferon
37%
Interleukin 6
25%
T Cell
12%
Reverse-Transcriptase Inhibitor
12%
Triacylglycerol
12%
Tumor Necrosis Factor Receptor
12%
Zidovudine
12%
Didanosine
12%
Blood Plasma
12%